secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPRUCE BIOSCIENCES, INC. (SPRB)
CIK:        0001683553
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0000950170-25-058863
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.05, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spruce Biosciences cuts 55% workforce; Nasdaq to delist stock on April 29
-------------------------------------------------------------------------

- Workforce reduction of 55% approved by Board; estimated $0.9M cash charges in Q2 2025.
- Reduction prioritizes development of tralesinidase alfa for Sanfilippo Syndrome Type B.
- Nasdaq delisting notice received April 22; trading suspended at open on April 29, 2025.
- Stock expected to trade OTC under SPRB; appealing to Hearings Panel; seeking reverse stock split at annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1683553/000095017025058863/0000950170-25-058863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1683553/000095017025058863/sprb-20250421.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-058863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer